Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravit Geva

Showing results (51-60 of 90) with videos related to

Pageof 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2016
Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 StudyRita Nanda, Laura Q M Chow, E Claire Dees, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|June 15, 2019
Resection Versus Observation of Small Asymptomatic Nonfunctioning Pancreatic Neuroendocrine TumorsAlex Barenboim, Guy Lahat, Ido Nachmany, et al.
Langenbeck'S Archives of Surgery|March 25, 2025
MRI is more accurate than FDG-PET in assessing complete response in rectal cancer patients after neoadjuvant therapyYehuda Kariv, Ronen Berkovitz, Reut El-On, et al.
JCO Precision Oncology|July 28, 2018
Rucaparib Monotherapy in Patients With Pancreatic Cancer and a Known Deleterious <i>BRCA</i> MutationRachna T Shroff, Andrew Hendifar, Robert R McWilliams, et al.
Annals of Surgical Oncology|April 22, 2020
Increased Rate of Complete Pathologic Response After Neoadjuvant FOLFIRINOX for BRCA Mutation Carriers with Borderline Resectable Pancreatic CancerTalia Golan, Alex Barenboim, Guy Lahat, et al.
Nutrients|December 28, 2021
Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Results of a Prospective Phase II StudyDaniel Keizman, Moshe Frenkel, Avivit Peer, et al.
Nutrients|August 26, 2023
Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II StudyDaniel Keizman, Moshe Frenkel, Avivit Peer, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 5, 2021
Cancer Therapeutics-related Cardiac Dysfunction in Patients Treated With Immune Checkpoint Inhibitors: An Understudied ManifestationShira Peleg Hasson, Joshua Arnold, Ilan Merdler, et al.
Surgical Oncology|August 15, 2024
The effect of long-standing lymphopenia after radiation therapy on survival in rectal cancerViacheslav Soyfer, Eli Lugovoy, Alla Nikolaevski-Berlin, et al.
Molecular Cancer Therapeutics|August 13, 2011
BRCA mutation status and determinant of outcome in women with recurrent epithelial ovarian cancer treated with pegylated liposomal doxorubicinTamar Safra, Lucia Borgato, Maria Ornella Nicoletto, et al.
Pageof 9

Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2016
Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 StudyRita Nanda, Laura Q M Chow, E Claire Dees, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|June 15, 2019
Resection Versus Observation of Small Asymptomatic Nonfunctioning Pancreatic Neuroendocrine TumorsAlex Barenboim, Guy Lahat, Ido Nachmany, et al.
Langenbeck'S Archives of Surgery|March 25, 2025
MRI is more accurate than FDG-PET in assessing complete response in rectal cancer patients after neoadjuvant therapyYehuda Kariv, Ronen Berkovitz, Reut El-On, et al.
JCO Precision Oncology|July 28, 2018
Rucaparib Monotherapy in Patients With Pancreatic Cancer and a Known Deleterious <i>BRCA</i> MutationRachna T Shroff, Andrew Hendifar, Robert R McWilliams, et al.
Annals of Surgical Oncology|April 22, 2020
Increased Rate of Complete Pathologic Response After Neoadjuvant FOLFIRINOX for BRCA Mutation Carriers with Borderline Resectable Pancreatic CancerTalia Golan, Alex Barenboim, Guy Lahat, et al.
Nutrients|December 28, 2021
Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Results of a Prospective Phase II StudyDaniel Keizman, Moshe Frenkel, Avivit Peer, et al.
Nutrients|August 26, 2023
Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II StudyDaniel Keizman, Moshe Frenkel, Avivit Peer, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 5, 2021
Cancer Therapeutics-related Cardiac Dysfunction in Patients Treated With Immune Checkpoint Inhibitors: An Understudied ManifestationShira Peleg Hasson, Joshua Arnold, Ilan Merdler, et al.
Surgical Oncology|August 15, 2024
The effect of long-standing lymphopenia after radiation therapy on survival in rectal cancerViacheslav Soyfer, Eli Lugovoy, Alla Nikolaevski-Berlin, et al.
Molecular Cancer Therapeutics|August 13, 2011
BRCA mutation status and determinant of outcome in women with recurrent epithelial ovarian cancer treated with pegylated liposomal doxorubicinTamar Safra, Lucia Borgato, Maria Ornella Nicoletto, et al.
Pageof 9